{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:49:13Z","timestamp":1791298153505,"version":"4.1.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Fanconi anemia (FA) is an autosomal recessive condition associated with bone marrow failure (BMF) leading to death or hematopoietic stem cell transplantation, acute myeloid leukemia (AML), and solid tumors (STs). It is unclear which patients are most likely to develop each outcome. From a cohort of 144 North American patients with FA, we calculated individualized risks of each outcome, given the presence or absence of readily diagnosed congenital abnormalities that occur frequently in FA. Abnormal radii and a 5-item congenital abnormality score were significant risk factors for BMF. The cumulative incidence of BMF by age 10 years varied from 18% in the lowest BMF risk group to 83% in the highest. Because of competing risks, patients in the lowest BMF risk group were most likely to live long enough to develop AML or ST, and, conversely, patients in the highest BMF risk group were least likely to live long enough to develop AML or ST. By age 40, the cumulative incidence of ST ranged from 0.6% to 29% in the highest and lowest BMF risk groups, respectively. Abnormal radii are the strongest predictor of early BMF in FA; a congenital abnormality score separates patients with normal radii into distinct prognostic groups. (Blood. 2004;104:350-355)<\/jats:p>","DOI":"10.1182\/blood-2004-01-0083","type":"journal-article","created":{"date-parts":[[2004,4,6]],"date-time":"2004-04-06T00:13:07Z","timestamp":1081210387000},"page":"350-355","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":69,"title":["Individualized risks of first adverse events in patients with Fanconi anemia"],"prefix":"10.1182","volume":"104","author":[{"given":"Philip S.","family":"Rosenberg","sequence":"first","affiliation":[{"name":"From the Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD; the Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; the Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[{"name":"From the Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD; the Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; the Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanche P.","family":"Alter","sequence":"additional","affiliation":[{"name":"From the Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD; the Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; the Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223121120600_REF1","unstructured":"Young NS, Alter BP. Aplastic Anemia: Acquired and Inherited. Philadelphia, PA: W.B. Saunders; 1994."},{"key":"2020021223121120600_REF2","doi-asserted-by":"crossref","unstructured":"Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet.2001;2: 446-457.","DOI":"10.1038\/35076590"},{"key":"2020021223121120600_REF3","doi-asserted-by":"crossref","unstructured":"Yamashita T, Nakahata T. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes. Int J Hematol.2001;74: 33-41.","DOI":"10.1007\/BF02982547"},{"key":"2020021223121120600_REF4","doi-asserted-by":"crossref","unstructured":"Meetei AR, de Winter JP, Medhurst AL, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet.2003;35: 165-170.","DOI":"10.1038\/ng1241"},{"key":"2020021223121120600_REF5","doi-asserted-by":"crossref","unstructured":"Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science.2002;297: 606-609.","DOI":"10.1126\/science.1073834"},{"key":"2020021223121120600_REF6","doi-asserted-by":"crossref","unstructured":"D'Andrea AD, Grompe M. The Fanconi anaemia\/BRCA pathway. Nat Rev Cancer.2003;3: 23-34.","DOI":"10.1038\/nrc970"},{"key":"2020021223121120600_REF7","doi-asserted-by":"crossref","unstructured":"Levran O, Erlich T, Magdalena N, et al. Sequence variation in the Fanconi anemia gene FAA. Proc Natl Acad Sci U S A.1997;94: 13051-13056.","DOI":"10.1073\/pnas.94.24.13051"},{"key":"2020021223121120600_REF8","doi-asserted-by":"crossref","unstructured":"Wijker M, Morgan NV, Herterich S, et al. Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet.1999; 7: 52-59.","DOI":"10.1038\/sj.ejhg.5200248"},{"key":"2020021223121120600_REF9","doi-asserted-by":"crossref","unstructured":"Verlander PC, Kaporis A, Liu Q, et al. Carrier frequency of the IVS4 + 4A \u2192 T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood.1995;86: 4034-4038.","DOI":"10.1182\/blood.V86.11.4034.bloodjournal86114034"},{"key":"2020021223121120600_REF10","doi-asserted-by":"crossref","unstructured":"Gibson RA, Morgan NV, Goldstein LH, et al. Novel mutations and polymorphisms in the Fanconi anemia group C gene. Hum Mutat.1996;8: 140-148.","DOI":"10.1002\/(SICI)1098-1004(1996)8:2<140::AID-HUMU6>3.0.CO;2-F"},{"key":"2020021223121120600_REF11","doi-asserted-by":"crossref","unstructured":"Demuth I, Wlodarski M, Tipping AJ, et al. Spectrum of mutations in the Fanconi anaemia group G gene, FANCG\/XRCC9. Eur J Hum Genet.2000;8: 861-868.","DOI":"10.1038\/sj.ejhg.5200552"},{"key":"2020021223121120600_REF12","doi-asserted-by":"crossref","unstructured":"Auerbach AD, Greenbaum J, Pujara K, et al. Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study. Hum Mutat.2003;21: 158-168.","DOI":"10.1002\/humu.10166"},{"key":"2020021223121120600_REF13","doi-asserted-by":"crossref","unstructured":"Tipping AJ, Pearson T, Morgan NV, et al. Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. Proc Natl Acad Sci U S A.2001;98: 5734-5739.","DOI":"10.1073\/pnas.091402398"},{"key":"2020021223121120600_REF14","doi-asserted-by":"crossref","unstructured":"Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood.1989;73: 391-396.","DOI":"10.1182\/blood.V73.2.391.391"},{"key":"2020021223121120600_REF15","doi-asserted-by":"crossref","unstructured":"Giampietro PF, Verlander PC, Davis JG, Auerbach AD. Diagnosis of Fanconi anemia in patients without congenital malformations: an international Fanconi Anemia Registry Study. Am J Med Genet.1997;68: 58-61.","DOI":"10.1002\/(SICI)1096-8628(19970110)68:1<58::AID-AJMG11>3.0.CO;2-N"},{"key":"2020021223121120600_REF16","doi-asserted-by":"crossref","unstructured":"Dokal I. The genetics of Fanconi's anaemia. Bail-lieres Best Pract Res Clin Haematol.2000;13: 407-425.","DOI":"10.1053\/beha.2000.0085"},{"key":"2020021223121120600_REF17","unstructured":"Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D, eds. Hematology of Infancy and Childhood. Philadelphia: W.B. Saunders Inc; 2003: 280-365."},{"key":"2020021223121120600_REF18","doi-asserted-by":"crossref","unstructured":"Koc A, Pronk JC, Alikasifoglu M, Joenje H, Altay C. Variable pathogenicity of exon 43del (FAA) in four Fanconi anaemia patients within a consanguineous family. Br J Haematol.1999;104: 127-130.","DOI":"10.1046\/j.1365-2141.1999.01156.x"},{"key":"2020021223121120600_REF19","doi-asserted-by":"crossref","unstructured":"Gillio AP, Verlander PC, Batish SD, Giampietro PF, Auerbach AD. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Blood.1997;90: 105-110.","DOI":"10.1182\/blood.V90.1.105"},{"key":"2020021223121120600_REF20","doi-asserted-by":"crossref","unstructured":"Futaki M, Yamashita T, Yagasaki H, et al. The IVS4 + 4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. Blood.2000;95: 1493-1498.","DOI":"10.1182\/blood.V95.4.1493.004k35_1493_1498"},{"key":"2020021223121120600_REF21","doi-asserted-by":"crossref","unstructured":"Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer.2003;97: 425-440.","DOI":"10.1002\/cncr.11046"},{"key":"2020021223121120600_REF22","unstructured":"Faivre L, Guardiola P, Lewis C, et al. Association of complementation group and mutation type with clinical outcome in Fanconi anemia. European Fanconi Anemia Research Group. Blood.2000; 96: 4064-4070."},{"key":"2020021223121120600_REF23","doi-asserted-by":"crossref","unstructured":"Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood.2003;101: 1249-1256.","DOI":"10.1182\/blood-2002-07-2170"},{"key":"2020021223121120600_REF24","doi-asserted-by":"crossref","unstructured":"Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood.2003;101: 822-826.","DOI":"10.1182\/blood-2002-05-1498"},{"key":"2020021223121120600_REF25","doi-asserted-by":"crossref","unstructured":"Alter BP, Caruso JP, Drachtman RA, et al. Fanconi anemia: myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet.2000;117: 125-131.","DOI":"10.1016\/S0165-4608(99)00159-4"},{"key":"2020021223121120600_REF26","doi-asserted-by":"crossref","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc Series B (Methodol).1972;34: 187-220.","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"2020021223121120600_REF27","doi-asserted-by":"crossref","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodol).1995;57: 289-300.","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"2020021223121120600_REF28","unstructured":"Westfall PH, Young SS. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment. Wiley-Interscience; 1993."},{"key":"2020021223121120600_REF29","doi-asserted-by":"crossref","unstructured":"Yekutieli D, Benjamini Y. Resampling-based false discovery rate controlling multiple test procedures for correlated test statistics. J Stat Plann Inference.1999;82: 171-196.","DOI":"10.1016\/S0378-3758(99)00041-5"},{"key":"2020021223121120600_REF30","doi-asserted-by":"crossref","unstructured":"Gaynor JJ, Feuer EJ, Tan CC, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc.1993;88: 400-409.","DOI":"10.1080\/01621459.1993.10476289"},{"key":"2020021223121120600_REF31","unstructured":"Hastie T, Tibshirani R. Generalized Additive Models. Chapman and Hall; 1990."},{"key":"2020021223121120600_REF32","doi-asserted-by":"crossref","unstructured":"Efron B, Tibshirani R. An Introduction to the Bootstrap. Chapman and Hall; 1994.","DOI":"10.1007\/978-1-4899-4541-9"},{"key":"2020021223121120600_REF33","doi-asserted-by":"crossref","unstructured":"Socie G, Devergie A, Girinski T, et al. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol.1998;103: 249-255.","DOI":"10.1046\/j.1365-2141.1998.00968.x"},{"key":"2020021223121120600_REF34","unstructured":"Guardiola P, Pasquini R, Dokal I, et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood.2000;95: 422-429."},{"key":"2020021223121120600_REF35","doi-asserted-by":"crossref","unstructured":"Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res.2001;125: 279-284.","DOI":"10.1016\/S0166-4328(01)00297-2"},{"key":"2020021223121120600_REF36","doi-asserted-by":"crossref","unstructured":"Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics.2003; 19: 368-375.","DOI":"10.1093\/bioinformatics\/btf877"},{"key":"2020021223121120600_REF37","unstructured":"Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat.1999;29: 1165-1188."},{"key":"2020021223121120600_REF38","doi-asserted-by":"crossref","unstructured":"Li X, Leteurtre F, Rocha V, et al. Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia. Br J Haematol.2003;120: 836-845.","DOI":"10.1046\/j.1365-2141.2003.04225.x"},{"key":"2020021223121120600_REF39","unstructured":"Guardiola P, Cassinat B, Chadelat C, et al. Malformative syndrome and serum alpha-fetoprotein level are predictors of the hematological outcome in Fanconi's anemia patients. Bone Marrow Transplantation.2003;31: S262."},{"key":"2020021223121120600_REF40","doi-asserted-by":"crossref","unstructured":"German J. Bloom's syndrome. Dermatol Clin.1995;13: 7-18.","DOI":"10.1016\/S0733-8635(18)30101-3"},{"key":"2020021223121120600_REF41","doi-asserted-by":"crossref","unstructured":"Hickson ID. RecQ helicases: caretakers of the genome. Nat Rev Cancer.2003;3: 169-178.","DOI":"10.1038\/nrc1012"},{"key":"2020021223121120600_REF42","doi-asserted-by":"crossref","unstructured":"Lehmann AR. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev.2001;15: 15-23.","DOI":"10.1101\/gad.859501"},{"key":"2020021223121120600_REF43","doi-asserted-by":"crossref","unstructured":"Shiloh Y, Kastan MB. ATM: genome stability, neuronal development, and cancer cross paths. Adv Cancer Res.2001;83: 209-254.","DOI":"10.1016\/S0065-230X(01)83007-4"},{"key":"2020021223121120600_REF44","unstructured":"Freedman MH, Bonilla MA, Fier C, et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood.2000;96: 429-436."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/2\/350\/1699683\/zh801404000350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/2\/350\/1699683\/zh801404000350.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T04:12:24Z","timestamp":1581567144000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/2\/350\/18306\/Individualized-risks-of-first-adverse-events-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,15]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,7,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-01-0083","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,15]]}}}